Analyst Ratings for NovaBay Pharmaceuticals (NBY)

NBY Rating Summary

  |   Expand Research on NBY
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/18/2019 Ladenburg Thalmann
» Updated 3/26/2021		 Jeffrey Cohen New Coverage Buy
(N/A)		 1.90
(1.75)		 0.53
(1.39)		 162.26% Details
3/13/2019 Laidlaw
» Updated 7/29/2019		 Francois Brisebois Downgrade Hold
(Buy)		 1.00
(0.75)		 1.50
(1.39)		 -7.33% Details